Cadrenal Therapeutics, Inc. (CVKD)
1.09
+0.09
(+9.00%)
USD |
NASDAQ |
Nov 06, 10:31
Cadrenal Therapeutics EPS Diluted (Quarterly) : -1.140 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.140 |
| March 31, 2026 | -1.037 |
| December 31, 2025 | -1.411 |
| September 30, 2025 | -1.314 |
| June 30, 2025 | -1.870 |
| March 31, 2025 | -2.085 |
| December 31, 2024 | -2.746 |
| September 30, 2024 | -2.181 |
| June 30, 2024 | -2.242 |
| Date | Value |
|---|---|
| March 31, 2024 | -1.558 |
| December 31, 2023 | -1.318 |
| September 30, 2023 | -1.194 |
| June 30, 2023 | -1.283 |
| March 31, 2023 | -6.62 |
| December 31, 2022 | -6.458 |
| September 30, 2022 | -1.323 |
| June 30, 2022 | -0.9756 |
| March 31, 2022 | -0.2277 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.323M |
| Total Expenses (Quarterly) | 3.323M |
| Enterprise Value | 0.7105M |
| Earnings Yield | -449.8% |
| Normalized Earnings Yield | -449.79 |